RxDoctor Payments DataLook up a doctor →

Leigh Perreault, MD

Endocrinology, Diabetes & Metabolism · Boulder, CONPI 1669562344

Payments from drug & device makers

$1,657,614in general payments, 2019–2025

Across 1,583 payments — averaging $1047.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$496K
  • Novo Nordisk$483K
  • Boehringer Ingelheim$260K
  • Sanofi-aventis U.S. LLC$122K
  • AstraZeneca$75K
  • Bayer$52K
  • plus $169K from 9 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,657,614 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.

See all endocrinology, diabetes & metabolism providers in Colorado

Medicare billing

Part B allowed, 2024
$10,170
Medicare patients
52
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Boulder

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →